Recent evidence has shown that microRNA-126 (miR-126) has been involved in the development and function of immune cells, which contributed to the pathogenesis of related clinical diseases. However, the potential role of miR-126 in the development and function of CD4 Furthermore, both the proliferation and IFN-g secretion of CFSE 1 cells also increased significantly in the CFSE-labelled miR-126KD CD4 1 T celltransferred group. Mechanistic evidence showed that the expression of insulin receptor substrate 1 (IRS-1), as a functional target of miR-126, was elevated in CD4 1 T cells from miR-126KD mice, accompanied by altered transduction of the extracellular regulated kinase, protein B (AKT) and nuclear factor kappa B (NF-jB) pathway. Our data revealed a novel role in which miR-126 was an intrinsic regulator in the function of CD4 1 T cells, which provided preliminary basis for exploring further the role of miR-126 in the development, function of CD4 1 T cells and related clinical diseases.
1
T cells from miR-126 knockdown (KD) mice using the miRNA-sponge technique were enhanced significantly in vitro, compared with those in CD4
1 T cells from wild-type (WT) mice. To monitor further the possible effect of miR-126 deficiency on the function of CD4 1 T cells in vivo, we used dextran sulphate sodium (DSS)-induced murine model of acute autoimmune colitis and found that miR-126 deficiency could elevate the pathology of colitis. Importantly, the proportion of CD4 1 T cells in splenocytes increased significantly in miR-126KD mice. Moreover, the expression levels of CD69 and CD44 on CD4 1 T cells increased significantly and the expression level of CD62L decreased significantly. Of note, adoptive cell transfer assay showed that the pathology of colitis was more serious in carboxyfluorescein succinimidyl ester (CFSE)-labelled miR-126KD CD4 1 T cell-transferred group, compared with that in the CFSE-labelled WT CD4 1 T cells transferred group. Consistently, the expression levels of CD69 and CD44 on CFSE 1 cells increased significantly.
Furthermore, both the proliferation and IFN-g secretion of CFSE 1 cells also increased significantly in the CFSE-labelled miR-126KD CD4 1 T celltransferred group. Mechanistic evidence showed that the expression of insulin receptor substrate 1 (IRS-1), as a functional target of miR-126, was elevated in CD4 1 T cells from miR-126KD mice, accompanied by altered transduction of the extracellular regulated kinase, protein B (AKT) and nuclear factor kappa B (NF-jB) pathway. Our data revealed a novel role in which miR-126 was an intrinsic regulator in the function of CD4 1 T cells,
Introduction
MicroRNA-126 (miRNA-126, miR-126) is an important member of microRNA families, localized within intron 7 of epidermal growth factor-like domain-containing protein 7 (EGFL7), and expressed highly in endothelial cells of blood vessel, heart and lung, as well as regulating the development of angiogenesis and cardiovascular diseases, etc. [1] [2] [3] [4] [5] . Some new evidence has shown further that miR-126 also plays an important role in the development of various cancers. For instance, Zhang et al. [6] have shown that miR-126 and miR-126* inhibits breast cancer metastasis by repressing the recruitment of mesenchymal stem cells and inflammatory monocytes. Other studies have also reported that the expression of miR-126 is down-regulated in lung cancer, gastric cancer and ovarian cancer, indicating that it is a promising new tumour suppressor gene [7] [8] [9] [10] .
Recently, significant progress also has been made in determining the role of miR-126 in the regulation of immunerelated diseases. For example, Feng et al. [11] reported that miR-126 expression is up-regulated during the development of ulcerative colitis, accompanied by inhibition of its target gene, IjBa. Zhang et al. [12] found that circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Importantly, numerous studies have documented that miR-126 also plays an important regulatory role in the function of various immune cells, such as plasmacytoid dendritic cells (pDCs), through changing the expression of vascular endothelial growth factor receptor 2 (VEGFR2) [13] . Moreover, Okuyama et al. [14] reported that miR-126, as a potential alternative to transcriptional factors, regulates the function of B cell myeloid progenitors. Interestingly, Zhao et al. [15] further found that the expression of miR-126 is up-regulated in CD4
1 T helper type 2 (Th2) cells from systemic lupus erythematosus disease, in which miR-126 could regulate DNA hypomethylation through DNA methyltransferase 1 (DNMT1). Similarly, our previous evidence also showed that miR-126 could regulate the function and induction of CD4 1 forkhead box protein 3 (Foxp3)
1 regulatory T cells through the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway [16] . However, the exact roles and mechanisms of miR-126 involved in the development and function of CD4
1 T cells and their distinct subsets remain to be elucidated fully.
In the present study, we first accessed the potential effect of miR-126 deficiency on the function of CD4 1 T cells from miR-126 knock-down (KD) mice using the miRNA-sponge technique. Our data show that the activation and proliferation, as well as the expression of interferon (IFN)-g, of CD4
1 T cells from miR-126KD mice, is enhanced significantly in vitro. Importantly, we found that miR-126 deficiency could also elevate the activation, proliferation and expression of IFN-g of CD4 1 T cells in vivo, which ultimately promotes the pathology of colitis in the dextran sulphate sodium (DSS)-induced murine autoimmune colitis mode. Finally, we found that the expression of insulin receptor substrate 1 (IRS-1), as a functional target of miR-126, is elevated in CD4 1 T cells from miR-126KD mice, accompanied by altered transduction of the extracellular regulated kinase (ERK), kinase, protein B (AKT) and nuclear factor kappa B (NF-jB) pathway. Thus, our data reveal a novel role in which miR-126 is an intrinsic regulator in the function of CD4 1 T cells, which provides a preliminary basis for further exploration into the role of miR-126 in the development and function of CD4 1 T and their subsets, as well as related clinical diseases.
Materials and methods

Mice
We established Friend leukaemia virus B (FVB)/N miR-126KD mice (8-10 weeks old, n 5 8) using the plasmids encoding enhanced green fluorescent protein (pEGFP)-C2-miR-126 sponge sequence with the help of Cyagen Biosciences Inc. (Santa Clara, CA, USA). All animals were housed under specific pathogen-free conditions at Zunyi Medical College, and all animal experiments were performed according to the guidelines for the Care and Use of Laboratory Animals (Ministry of Health, China, 1998). All the experimental procedures were approved by the ethical guidelines of Zunyi Medical College Laboratory Animal Care and Use committee (permit number 2014026).
Preparation of single-cell suspensions
We collected spleen from female wild-type (WT) FVB/N mice (8-10 weeks old) and miR-126KD mice, respectively. Then spleen was put into gentle magnetic affinity cell sorting (MACS) C tubes loaded with 7 ml PBE [PBS 1 0.5% fetal bovine serum (FBS) and ethylenediamine tetraacetic acid (EDTA)]. The program of m_spleen_01 was selected and was taken for 56 s. After completion of the program, the cells were filtered using a 200-mesh sterile cells strainer, and the whole cell suspension was spun down at 265 (3g) and 48C for 10 min. We discarded the supernatant and added 3 ml red blood cell (RBC) pyrolysis liquid to resuspend the cell pellets on ice for 15 min. Then, a 10 ml PBS suspension of splenocytes was added, filtered by a 200-mesh sterile cells strainer, repeated twice, into a new 15-ml centrifuge tube for the next experimental protocol.
suitable MACS separator. The column was prepared by rinsing with 2 ml of 0Á5% PBE and the cell suspension was applied onto the column; the column was then washed with 2 ml of 0Á5% PBE. The flow-through containing unlabelled cells was collected, then 1 ml 0Á5% PBE was added to the LD column twice, squeezing the liquid with piston. Then, the flow-through containing labelled cells was collected, representing the enriched CD4
1
CD62L
1 T cells.
T cell activation, proliferation and electroporation transfection Real-time polymerase chain reaction (PCR) assay 
Induction of autoimmune colitis
Three percent DSS was purchased from MP Biomedicals (Strasbourg, France) in drinking water. Mice were administered orally with distilled water. After drinking for 10 days instead of normal drinking water, the mice were euthanized on day 14 (the mice were only drinking distilled water for contrast). Then, the entire colon was removed and measured for length.
Assessment of the severity of colitis and histology
Pathology and histology were scored using a previously validated scoring system [17, 18] . Pathology was scored as follows: (i) weight loss (no change 5 0, < 5% 5 1, 6-10% 5 2, 11-20% 5 3, > 20% 5 4); (ii) faeces (normal 5 0, pasty, semiformed 5 2, liquid, sticky or unable to defecate after 5 min 5 4), (iii) blood (no blood 5 0, visible blood in rectum 5 1, visible blood on fur 5 2); and (iv) general appearance (normal 5 0, piloerection 5 1, lethargy and piloerection 5 2, motionless, sickly 5 4). For histological examination, the colons were removed, rolled around a cotton swab, fixed in 10% formaldehyde and paraffin-embedded. The paraffin blocks were sectioned serially longitudinally with at a thickness of 5 mm and were stained with haematoxylin and eosin (H&E) to allow histological examination of whole colons at 3100 and 3400 magnification by light microscopy. Histology was scored as follows: (i) inflammation severity: none 5 0, slight 5 1, moderate 5 2, severe 5 3; (ii) depth of injury: none 5 0, mucosal 5 1, mucosal and submucosal 5 2, transmural 5 3; (iii) crypt damage: none 5 0, basal one-third damaged 5 1, basal two-thirds damaged 5 2, only surface epithelium intact 5 3, entire crypt and epithelium lost 5 4; and (iv) percentage of area involved: none 5 0, 1-25% 5 1, 26-50% 5 2, 51-75% 5 3, 76-100% 5 4. The final scores are the averages of all individual scores of six pieces per colon.
Adoptive transfer experiment
In the adoptive transfer model, 10 6 cells/ml CD4 1 CD62L
1
T cells purified from WT or miR-126KD mice by MACS were resuspended in RPMI-1640 medium. Then 2 ll carboxyfluorescein succinimidyl ester (CFSE) was added to cell fluid per millilitre of liquid, followed by 2 ml PBS buffer solution. After 30 min at 378C, 35 vol liquid PBE was added gently to stop staining. Cells were terminated, respectively, according to 10 7 cells in each mouse by intravenous (i.v.) tail injection to WT mice and 3% DSS water solution feeding; the mice were euthanized on day 14.
Western blotting
Western blotting was performed on cytosolic cellular extracts. Equal amounts of protein were resolved under reducing conditions on a 10% sodium dodecyl sulphate-polyacrylamide gel (SDS-PAGE). Protein migration was assessed using protein standards (Bio-Rad). Transfer to a nitrocellulose membrane was performed for 1 h at 250 mA using a wet transfer system. Equal protein loading was confirmed with Ponceau staining. The membrane was washed in 5% skimmed milk in PBS plus 0Á05% Tween 20 (PBST) for 2 h to block nonspecific protein-binding sites on the membrane. Immunoblotting was performed using a mAb to IRS-1 (Cell Signaling Technology; no. 2390) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Cell Signaling Technology; no. 4970) at a dilution of 1 : 800 in a non-fat milk-Tris buffer. The membrane was then washed in PBST and probed subsequently with a secondary antimouse or rabbit antibody conjugated to horseradish peroxidase (HRP) (Cell Signaling Technology; no. 7074) at a dilution of 1 : 2000. The signal was detected and analysed using the chemiluminescence imaging system (ChemiScope5600; Clinx, Shanghai, China). Each experiment was performed in triplicate.
Construction of the IRS-1 RNAi vector
We designed a synthesis of the sequence of IRS-1 RNAi: sense:
0 and then subcloned into BamHI and EcoRI sites of pLVX-shRNA1. The plasmid DNA sequence was confirmed by sequencing.
Statistical analyses
Statistical analyses of the data were performed with GraphPad Prism TM (Graphpad Software Inc., San Diego, CA, USA) and the aid of analysis programs in SPSS version 16.0 software. All data are presented as the mean X 6 S. Student's t-test was used when two conditions were compared, and analysis of variance with Bonferroni or Newman-Keuls correction was used for multiple comparisons. Probability values of < 0Á05 were considered significant.
Results
Mir-126 deficiency enhanced the activation and proliferation of CD4 1 
T cells in vitro
To investigate the potential role of miR-126 in the function of CD4 1 T cells, we first detected the relative expression of miR-126 in various organs and tissues. As shown in Supporting information, Fig. S1a , we found that the relative expression level of miR-126 was higher in spleen than in other immune organs (P < 0Á05). However, we further found that the expression of miR-126 decreased significantly in CD4
1 T cell-deprived splenocytes (Supporting information, Fig. S1b , P < 0Á05), indicating that miR-126 might be expressed predominantly in CD4 1 T cells. We then generated miR-126KD mice using the miRNA-sponge technique, according to our recent work [19] . As shown in Supporting information, Fig. S2 , the expression levels of miR-126 in indicated organs and tissues decreased significantly in miR-126KD mice compared with those in WT mice (P < 0Á05). Importantly, our data showed further that the proportion of CD4
1 T cells increased significantly in splenocytes in miR-126KD mice compared with that in control mice (Supporting information, Fig. S3a ,b, P < 0Á05). These data suggest that miR-126 might be involved in the development and function of CD4 1 T cells. To study further the exact role of miR-126 in the function of CD4
1 T cells, we purified CD4 1 CD62L 1 T cells from miR-126KD mice and observed the possible change in activation and function. Expectedly, our results showed that the relative expression of miR-126 decreased significantly in CD4
1 T cells from miR-126KD mice compared with the WT mice group (Fig. 1a, P < 0Á01) . Importantly, we found that the expression levels of surface active molecules, including CD44 and CD69, were elevated in CD4 1 T cells from miR-126KD mice stimulated by anti-CD3/anti-CD28 antibody (Fig. 1b,c, P < 0Á05) . Conversely, these CD4 1 T cells expressed lower level of CD62L (Fig. 1b ,c, P < 0Á05), indicating an enhanced activation phenotype. We further detected the expression of intracellular proliferating nuclear antigen Ki-67 in CD4
1 T cells, and found that the proportion of Ki-67 1 in CD4 1 T cells from miR-126KD mice increased significantly (Fig. 1d ,e, P < 0Á001). To confirm this finding further, we also detected the proliferation of CD4 1 T cells stimulated by concanavalin A (ConA) and obtained similar results (Supporting information, Fig. S4a ,b, P < 0Á01). Finally, we also found that the apoptosis proportion of CD4 1 T cells did not change significantly (Fig. 1f,g , P > 0Á05). All these data suggest that miR-126 deficiency could clearly enhance the activation and proliferation capacity of CD4 1 T cells in vitro. (Fig. 2a, P < 0Á05) . Conversely, we found that the expression levels of cytokines including IL-12, TGF-b, TNF-a and IFN-g were higher in CD4 1 T cells from miR-126KD mice ( Fig. 2a, P < 0Á05) , even though the level of expression of cytokine IL-6 in CD4 1 T cells from miR-126KD mice did not change significantly compared with WT mice (Fig. 2a, P > 0Á05) . To confirm this phenomenon, we further detected the proportion of relative cytokines of CD4 1 T cells by flow cytometry. As shown in Fig. 2b ,c, the proportion of IL-4
MiR-126 affects T cell activation and function
1 cells in CD4
1
T cells from miR-126KD mice decreased significantly compared with that in CD4 1 T cells from WT mice (P < 0Á01). Meanwhile, the proportion of IFN-g 1 cells increased noticeably (Fig. 2b ,c, P < 0Á05). In addition, we found that the proportion of IL-17A 1 cells in CD4 1 T cells from miR-126KD mice did not change significantly (Fig. 2b,c , P > 0Á05). Collectively, these data suggest that miR-126 deficiency also could alter secretion of related cytokines in CD4
1 T cells in vitro.
Mir-126 deficiency promoted the pathology of DSS-induced autoimmune colitis
It is well known that DSS-induced autoimmune colitis is an important animal model platform for the exploration on immune reaction in inflammatory bowel disease in vivo, in which effector CD4 1 T cells play a critical role in the pathology of colitis [20] . To investigate further whether miR-126 deficiency could affect the activation and function of CD4
1
T cells in vivo, we established murine DSSinduced autoimmune colitis (Fig. 3a) and observed the possible change on pathology of colitis. As shown in Fig.  3b ,c (P < 0Á05), the clinical and histological scores indicated that the liquid and sticky defecate correlated significantly with weight loss in the miR-126KD mice group compared with that in the WT mice group, and the mucosal epithelium appeared as a larger ulcer in the miR-126KD mice group. Moreover, the infiltration of inflammatory cells also clearly increased. Importantly, we found that the percentage and total cell number of CD4 1 T cells in splenocytes increased clearly in the miR-126KD mice group compared with those in the WT mice group (Fig. 3d ,e, P < 0Á05). Further analysis showed that the expression level of CD62L on CD4 1 T cells decreased significantly (Fig.  3f ,g, P < 0Á05) and the level of CD44 in CD4 1 T cells in the miR-126KD mice group clearly increased (Fig. 3f ,g, P < 0Á05), indicating an elevated activation phenotype. Combining these data suggested that miR-126 deficiency could promote the pathology of DSS-induced autoimmune colitis, which might be related to an elevated activation and function of CD4 1 T cells. 
MiR-126 deficiency endowed CD4 1 T cells to aggravate the pathology of DSS-induced autoimmune colitis
To verify the effect of miR-126 deficiency on the activation and function of CD4 1 T cells in vivo, we purified and labelled CD4
1 CD62L 1 T cells from miR-126KD mice with CFSE, then transferred these cells adoptively into normal WT mice through the tail vein (Fig. 4a) . Our data show that the length of colon was shortened significantly in the miR-126KD CD4
1 T cell-transferred group, compared with that in the WT CD4 1 T cell-transferred group (Fig.  4b ,c, P < 0Á05). Clinical and histological examination showed that the liquid and sticky defecate correlated significantly with weight loss in the miR-126KD CD4 1 T cell-transferred group compared with that in the WT CD4 1 T cell-transferred group. Furthermore, intestine tissue damage was aggravated and inflammatory cell infiltration increased significantly in the miR-126KD CD4 1 T cell-transferred group (Fig. 4d ,e, P < 0Á05). Notably, we found that the expression level of CD62L on CFSE 1 cells decreased significantly in the miR-126KD CD4 1 T celltransferred group (Fig. 4f,g, P < 0Á05) , and the level of CD44 on CFSE 1 cells clearly increased (Fig 4h,i , P < 0Á05), which was consistent with our above data. Next, we analysed further the possible change in the proliferation and cytokine secretion of CD4 1 T cells in vivo. As shown in Fig. 4j ,k, the proportion of Ki-67-positive, a type of proliferating cell nuclear antigen, in CFSE 1 cells was elevated significantly in the miR-126KD CD4 1 T cell-transferred group, compared with that in the WT CD4 1 T celltransferred group (P < 0Á05). Furthermore, we found that the proportion of IFN-g 1 in CFSE 1 cells also increased significantly (Fig. 4l ,m, P < 0Á05). Consistent with our above data, the proportion of IL-4 1 in CFSE 1 cells clearly decreased (Fig. 4l ,m, P < 0Á01). Collectively, all these data demonstrate that miR-126 deficiency endowed CD4
1 T cells with an enhanced activation and function capacity to aggravate the pathology of DSS-induced autoimmune colitis.
MiR-126 deficiency altered the expression of IRS-1
To elucidate the potential molecular mechanism by which miR-126 deficiency enhanced the activation and function of CD4
1 T cells, we used an miRNA target detection program (http://www.microrna.org) to predict the potential target genes of miR-126 and selected 13 potential candidate genes, including phosphomannomutase 1 (PMM1), target of Myb1 membrane trafficking protein (Tom1), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta (PIK3CD), regulator of G protein signalling 3 (RGS3), tuberous sclerosis 1 (TSC1), insulin receptor substrate 1 (IRS-1), ADAM metallopeptidase domain 9 (ADAM9), EGF-like domain multiple 7 (EGFL7), vascular cell adhesion molecule 1 (VCAM1), PHD finger protein 7 (Phf7), solute carrier family 39 member 6 (SLC39a6), Huntingtin interacting protein 1 (HIP1) and poly(ADP-ribose) polymerase family member 16 (PARP16P). Then, the relative expression of these genes indicated on CD4 1 T cells between WT mice and miR-126KD mice was analysed. As shown in Fig. 5a , among these 13 candidate genes, the expression of IRS-1 was up-regulated significantly in CD4 1 T cells from miR-126KD mice compared with that from WT mice. Previous work has shown that miR-126 could regulate the biological characters of various cells, including cancer cells, through IRS-1 [21] [22] [23] , and IRS-1 was also reported to play an important role in the function of various immune cells [24] . We performed a sequence alignment analysis and found expectedly that miR-126-binding sites in the 3'UTR of IRS-1 (Fig. 5b) . Next, we detected the protein level of IRS-1 in CD4
1 T cells from miR-126KD mice. As shown in Fig. 5c , the level of IRS-1 protein in CD4 1 T cells from miR-126KD mice was increased significantly, compared with that in WT mice (P < 0Á05). Finally, to verify the role of IRS-1 in the effect of miR-126 deficiency on the activation and function of CD4 1 T cells, we also transfected IRS-1 RNAi into CD4 1 T cells from miR-126KD mice. As shown in Fig. 5d , the relative expression of IRS-1 in CD4 1 T cells in the IRS-1 RNAi-transfected group decreased significantly, compared with that in the control group (P < 0Á01). Furthermore, the proliferation of CD4
1
T cells in the IRS-1 RNAi-transfected group also clearly decreased ( Fig. 5e, P < 0Á05) . Importantly, we also found that the expression levels of CD69 and CD44 in CD4 1 T cells decreased significantly ( Fig. 5f -i, P < 0Á05), indicating that down-regulation of IRS-1 could impair the CD4 1 T cell activation in miR-126KD mice. To confirm this phenomenon, we also detected the expression of related cytokines in CD4 1 T cells. Consistently, we found that the expression of IFN-g in CD4 1 T cells in the IRS-1 RNAitransfected group decreased significantly compared with those in the control group (Fig. 5j ,k, P < 0Á05). Conversely, the expression level of cytokine IL-4 was higher in CD4 1 T cells in the IRS-1 RNAi-transfected group (Fig. 5j ,k, P < 0Á05). Collectively, our data indicate that miR-126 deficiency enhances the activation and function of CD4 1 T cells, which is due closely to the up-regulation expression of its target IRS-1.
MiR-126 deficiency altered the transduction of related signalling pathways in CD4 1 T cells
It is well known that multiple signalling pathways are related to the activation and function of CD4 1 T cells, including ERK, AKT, NF-jB, etc. [25] [26] [27] [28] [29] . Moreover, IRS-1 was also reported to be related closely to the transduction of these signalling pathways [22, [30] [31] [32] . Thus, to elucidate whether miR-126 deficiency affected the activation and function of CD4 1 T cells was related to the change in these signalling pathways, the expression levels of phosphorylation of AKT, ERK and NF-jB were analysed in CD4 1 T cells purified from miR-126KD mice and WT mice, respectively. As shown in Fig. 6a ,b, the ERK phosphorylation expression level in CD4 1 T cells from miR-126KD mice was elevated compared with that from WT mice (P < 0Á05). Moreover, we found that the level of phosphorylation of AKT in these CD4 1 T cells increased significantly (Fig. 6a,b , P < 0Á01).
Finally, we analysed the expression level of phosphorylation of NF-jB in CD4 1 T cells from miR-126KD mice and obtained similar results (Fig. 6a,b , P < 0Á01). Combining these results suggested that the effects of miR-126 deficiency on the activation and function of CD4 1 T cells are related closely to the altered transduction of ERK, AKT and NF-jB signalling pathway (Fig. 6c) . [33] [34] [35] [36] [37] . Increasing evidence demonstrates that the distinct miRNA molecule plays a critical regulatory role in the development and function of various immune cells, including CD4 1 T cells, which affect the pathogenesis and development of related clinical diseases [38] [39] [40] [41] [42] [43] [44] . For example, Zeng et al. [45] reported that down-regulation of miR-451a affects the activation and proliferation of CD4 1 T cells by targeting the transcription factor myelocytomatosis oncogene (Myc) in dilated cardiomyopathy (DCM) patients, which contribute to the immunopathogenesis of DCM. Our new research work also reports that miR-7 deficiency alters the proportion and absolute number of CD4 1 T cells in bronchoalveolar lavage (BAL), while it is related to ameliorated pathologies of acute lung injury [19] . In the present study, we extend previous findings by demonstrating that miR-126 deficiency could clearly elevate activation and proliferation, as well as IFN-g secretion, in CD4
1 T cells, indicating that miR-126 might be a novel negative factor in CD4
1 T cell function. Similarly, Okuyama et al. [14] reported that miR-126 is a Similarly, in the present study, we found that miR-126 deficiency could alter the expression of IFN-g and IL-4, two critical representative cytokines for Th1 and Th2 subsets, suggesting that miR-126 is also critical for the biology of distinct CD4
1 T cell subsets. Therefore, successive research work into the possible role of miR-126 in these CD4
1 T cell subsets, such as CD4
1 Th1 or Th2 cells, is extremely important for verification of the exact biological role of miR-126 in the immune system.
Previous studies have documented that the change in biological function of CD4 1 T cells are related closely to the development of inflammatory bowel disease (IBD) [46, 47] . Moreover, accumulating evidence shows the irreplaceable role of distinct miRNA molecules in the occurrence and development of IBD [17, 48, 49] . For instance, Runtsch et al. [50] reported that miR-146a was involved in constraining intestinal barrier function. Moreover, miR146a deficiency was resistant to DSS-induced colitis. In our study, we found that miR-126 deficiency could promote the pathological change of colitis significantly in DSSinduced autoimmune colitis model mice. Simultaneously, the percentage and total number of CD4 1 T cells displayed an elevated activation phenotype, clearly increased in DSSinduced autoimmune colitis model mice. Most importantly, adoptive cell transfer assay showed further that miR-126 deficiency could endow CD4 1 T cells with an elevated activation, proliferation and IFN-g secretion capacity to aggravate the pathology of colitis in the DSS-induced autoimmune colitis model. In line with our findings, Holmkvist et al. [20] reported that the state of activation and function of CD4 1 T cells is correlated closely with the development of T cell-mediated immune colitis. Combining these data suggests strongly that miR-126 might be a novel potential regulator in the development of autoimmune colitis, at least partially through regulating the function of CD4 1 T cells. Hence, further studies on the correlation between miR-126 expression and clinical IBD patients, which were not investigated in the current study, would be very valuable for exploration into the exact role of miR-126 in the development of clinical IBD. IRS-1, a distinct member of the IRS family, is an important factor in the biological character of some types of cells, including cancer cells, which are related closely to transduction of the ERK, AKT and NF-jB pathway [30] . Regarding immune cells, Li et al. [48] reported that overexpression of IRS-1 could protect T cells from activationinduced cell death (AICD). Moreover, Stentz and Kitabchi [49] found that up-regulation of IRS-1 is involved in activation of CD4 1 T cells in response to hyperglycaemia. In the present study, our data show that, in miR-126 deficiency, the expression of IRS-1 in CD4 1 T cells is elevated, which is consistent with previous findings that miR-126 could regulate the biological character of various cells through IRS-1. Furthermore, we found that miR-126 deficiency also alters the transduction of the ERK, AKT and NF-jB pathway. Given the important role of this signal pathway in the activation, proliferation and cytokine secretion of CD4 1 T cells, we presume that miR-126 deficiency affects the activation and function of CD4 1 T cells, which is related to the up-regulation of IRS-1 and subsequently alters the transduction of the related signalling pathway. However, because of the complex of miRNA-target networks, whether or not miR-126 regulates the activation and function of CD4 1 T cells through controlling the expression of other potential molecules still remains to be elucidated fully in future. Altogether, our present data reveal the unknown biological role of miR-126 to be a novel intrinsic negative regulator in the function of CD4 1 T cells, which provides a new fundamental basis for exploring further the role of miR-126 in the development and function of immune cells and their subsets, as well as the occurrence and development of related diseases.
Supporting information
Additional Supporting information may be found in the online version of this article at the publisher's web-site: Fig. S1 . The relationship between microRNA-126 (Mir-126) and CD4 1 T cells. Kidney, liver, lung, brain, intestine, heart, spleen, thymus, lymph node, bone, muscle and skin were collected from wild-type (WT) mice (6-8 weeks old, n 5 6). (a) The relative expression of miR-126 in those 12 tissues and organs were analysed by real-time polymerase chain reaction (RT-PCR) and calculated. (b) CD4 1 T cells were purified by magnetic-activated cell sorting (MACS). Then, the relative expression of miR-126 in CD4 1 T cells and CD4 1 T cell-deprived splenocytes were measured by RT-PCR assay and calculated. *P < 0Á05. Fig. S2 . The relative expression of microRNA-126 (Mir-126) in wild-type (WT) mice and miR-126 knock-down (KD) mice. Kidney, liver, lung, brain, intestine, heart, spleen, thymus, lymph node, bone and muscle, as well as skin, were collected from WT mice (6-8 weeks old, n 5 6) and miR-126KD mice (6-8 weeks old, n 5 6).
The relative expression of miR-126 in those indicated tissues and organs were analysed by real-time polymerase chain reaction (RT-PCR) and calculated. *P < 0Á05; **P < 0Á01. One of three independent experiments is shown. *P < 0Á05. 
